Brochure
2 Feb 2024
REGULATORY AFFAIRS SERVICES
![](/SciencePharma_logo_poziom_kolor-file133346.jpg)
PDF 3.3 MB
Content provided by our supplier
SciencePharma
![SciencePharma](/SciencePharma_logo_poziom_kolor-comp272906.jpg)
-
PL
-
2018On CPHI since
-
50 - 99Employees
Company types
Primary activities
Other Content from SciencePharma (1)
-
News BOTULINUM NEUROTOXINS TYPE A AND B
SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite you to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance